2,268
Views
12
CrossRef citations to date
0
Altmetric
Obesity

Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 365-373 | Received 12 Sep 2017, Accepted 12 Dec 2017, Published online: 10 Jan 2018

References

  • Abdullah A, Peeters A, de Courten M, et al. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract 2010;89:309-19
  • Huerta JM, Tormo MJ, Chirlaque MD, et al. Risk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain; a Mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort study. BMC Endocr Disord 2013;13:7
  • Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007;167:1720-8
  • Strazzullo P, D’Elia L, Cairella G, et al. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 2010;41:e418-26
  • Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension; diabetes; dyslipidemia; and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey; 1999 to 2004. J Am Coll Surg 2008;207:928-34
  • Butterworth PA, Landorf KB, Smith SE, et al. The association between body mass index and musculoskeletal foot disorders: a systematic review. Obes Rev 2012;13:630-42
  • Lim SS, Norman RJ, Davies MJ, et al. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 2013;14:95-109
  • Heslehurst N, Simpson H, Ells LJ, et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev 2008;9:635-83
  • Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78
  • Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev 2014;(8):CD003641
  • Drummond MFSM, Torrance GW, O’Brien BJ, et al. Methods for the economic evaluation of health care programmes. Third edition. Oxford: Oxford University Press; 2005
  • Borisenko O, Adam D, Funch-Jensen P, et al. Bariatric surgery can lead to net cost savings to health care systems: results from a comprehensive European decision analytic model. Obes Surg 2015;25:1559-68
  • Briggs AH, Claxton K, Sculpher MJ. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006
  • Hansen LJ, Olivarius Nde F, Siersma V. 16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study. BMC Public Health 2009;9:400
  • Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 2004;364:849-57
  • Zanchetti A, Hansson L, Dahlof B, et al. HOT Study Group. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. J Hypertens 2001;19:1149-59
  • Witt BJ, Ballman KV, Brown RD Jr., et al. The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med 2006;119:354 e351–9
  • Ovbiagele B, Diener HC, Yusuf S, et al. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011;306:2137-44
  • Dennis MS, Burn JP, Sandercock PA, et al. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993;24:796-800
  • Velagaleti RS, Pencina MJ, Murabito JM, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 2008;118:2057-62
  • Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6
  • Rosengren A, Wilhelmsen L, Hagman M, et al. Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: a 16-year follow-up of the Primary Prevention Study; Goteborg; Sweden. J Intern Med 1998;244:495-505
  • Arnold JM, Yusuf S, Young J, et al. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation 2003;107:1284-90
  • Krumholz HM, Wang Y, Chen J, et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995–2006. JAMA 2009;302:767-73
  • Wolf PA, D’Agostino RB, O’Neal MA, et al. Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992;23:1551-5
  • Adams KF, Schatzkin A, Harris TB, et al. Overweight; obesity; and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763-78
  • Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight; overweight; and obesity. JAMA 2005;293:1861-7
  • McTigue K, Larson JC, Valoski A, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006;296:79-86
  • Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J 1991;121(1 Pt 2):293-8
  • D’Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-53
  • Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009;13:1-190;215–357;iii–iv
  • Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6
  • Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med 2017;376:641-51
  • Dillemans B, Sakran N, Van Cauwenberge S, et al. Standardization of the fully stapled laparoscopic Roux-en-Y gastric bypass for obesity reduces early immediate postoperative morbidity and mortality: a single center study on 2606 patients. Obes Surg 2009;19:1355-64
  • Scandinavian Obesity Surgery Registry (SOReg). Annual Report. Örebro. 2011. http://www.ucr.uu.se/soreg/component/edocman/arsrapport-soreg-2011
  • Himpens J, Cadiere GB, Bazi M, et al. Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg 2011;146:802-7
  • SPF Economie. Tables de mortalité et espérance de vie [Mortality and life expectancy tables]. Brussels. 2011. http://economie.fgov.be/fr/statistiques/chiffres/population/deces_mort_esp_vie/tables/
  • SPF Economie. Causes de décès [Causes of death]. Brussels. 2010. http://economie.fgov.be/fr/statistiques/chiffres/population/deces_mort_esp_vie/causes/
  • Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56-65
  • Sjöström L. Lifestyle; diabetes; and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93
  • Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes hypertension and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA 2013;309:2240-9
  • Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 2007;3:127-32; discussion 132–3
  • Bessler M, Daud A, Kim T, et al. Prospective randomized trial of banded versus nonbanded gastric bypass for the super obese: early results. Surg Obes Relat Dis 2007;3:480-4; discussion 484–5
  • Dixon JB, Brien PEO, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA 2008;299:316-23
  • Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss; appetite suppression; and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective; double blind study. Ann Surg 2008;247:401-7
  • Mathus-Vliegen EMH, de Wit LT. Health-related quality of life after gastric banding. Br J Surg 2007;94:457-65
  • Nguyen NT, Slone JA, Nguyen X-MT, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes; quality of life; and costs. Ann Surg 2009;250:631-41
  • Schauer P. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-76
  • Stoeckli R, Chanda R, Langer I, et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004;12:346-50
  • van Dielen FMH, Soeters PB, de Brauw LM, et al. Laparoscopic adjustable gastric banding versus open vertical banded gastroplasty: a prospective randomized trial. Obes Surg 2005;15:1292-8
  • Jönsson B, Board C-A. Revealing the cost of type II diabetes in Europe. Diabetologia 2002;45:S5-S12
  • Annemans L, Lamotte M, Levy E, et al. Cost-effectiveness analysis of clopidogrel versus aspirin in patients with atherothrombosis based on the CAPRIE trial. J Med Econ 2003;6:55-68
  • Annemans L, De Backer W, Van Rompay W, et al. CVB3 evaluation of the costs of coronary heart disease in Belgium. Value Health 1998;1:33
  • Wilson K, Hettle R, Marbaix S, et al. An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium; Spain; Portugal; and Italy. Eur J Prev Cardiol 2012;19:1173-83
  • National Institute for Health and Disability Insurance. INAMI Nomensoft: nomenclature des prestations de sante. Brussels. 2014. http://www.riziv.fgov.be/fr/nomenclature/Pages/default.aspx#.WVFwkuvyhaQ
  • Lambert M-L, Kohn L, Vinck I, et al. Belgian Health Care Knowledge Centre. Pharmacological and surgical treatment of obesity. Residential care for severely obese children in Belgium. Health Technology Assessment (HTA). Bruxelles: Belgian Health Care Knowledge Centre (KCE); 2006. KCE reports 36C (D/2006/10.273/30). https://kce.fgov.be/publication/report/pharmacological-and-surgical-treatment-of-obesity-residential-care-for-severely-o#.WWjdPYTyhaQ
  • Statistics Belgium. Consumer price index (CPI). Brussels. 2017. http://statbel.fgov.be/en/statistics/figures/economy/consumer_price_index/
  • Ackroyd R, Mouiel J, Chevallier JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg 2006;16:1488-503
  • Sullivan PW, Slejko JF, Sculpher MJ, et al. Catalogue of EQ-5D scores for the United Kingdom. Med Decis Making 2011;31:800-4
  • Cleemput I, Van Wilder P, Vrijens F, et al. Richtlijnen voor farmaco-economisch onderzoek in Belgie (Guidelines for Pharmacoeconomic Evaluations in Belgium). Brussels: KCE Reports; 2008: 78B ed2008. https://kce.fgov.be/nl/publication/report/richtlijnen-voor-farmaco-economische-evaluaties-in-belgi%C3%AB
  • Neyt M, Huybrechts M, Hulstaert F, et al. Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium. Health Policy 2008;87:146-59
  • OECD. “Smoking”. In OECD Factbook 2011–2012: Economic; Environmental and Social Statistics. Paris, France: OECD Publishing; 2011. http://www.oecd-ilibrary.org/economics/oecd-factbook_18147364
  • Verhaeghe N, De Greve O, Annemans L. The potential health and economic effect of a Body Mass Index decrease in the overweight and obese population in Belgium. Public Health 2016;134:26-33
  • Ikramuddin S, Klingman D, Swan T, et al. Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patients. Am J Manag Care 2009;15:607-15
  • Anselmino M, Bammer T, Fernández Cebrián JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries (II). Obes Surg 2009;19:1542-9
  • Belarbi S, Kusel J, Maruszczak M, et al. The cost-effectiveness of bariatric surgery in Germany. Value Health 2015;18:A393
  • Campbell J, McGarry LA, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity. Am J Manag Care 2010;16:e174-87
  • Faria GR, Preto JR, Costa-Maia J. Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model. Obes Surg 2013;23:460-6
  • Hoerger TJ, Zhang P, Segel JE, et al. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care 2010;33:1933-9
  • James R, Salton RI, Byrnes JM, et al. Cost-utility analysis for bariatric surgery compared with usual care for the treatment of obesity in Australia. Surg Obes Relat Dis 2017;13:2012-2020
  • Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care 2009;32:567-74
  • Lee YY, Veerman JL, Barendregt JJ. The cost-effectiveness of laparoscopic adjustable gastric banding in the morbidly obese adult population of Australia. PLoS One 2013;8:e64965
  • Maklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br J Surg 2011;98:1422-9
  • Wang BC, Wong ES, Alfonso-Cristancho R, et al. Cost-effectiveness of bariatric surgical procedures for the treatment of severe obesity. Eur J Health Econ 2014;15:253-63
  • Neovius M, Narbro K, Keating C, et al. Health care use during 20 years following bariatric surgery. JAMA 2012;308:1132-41
  • Weiner JP, Goodwin SM, Chang HY, et al. Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data. JAMA Surg 2013;148:555-62
  • Borisenko O, Colpan Z, Dillemans B, et al. Clinical indications; utilization; and funding of bariatric surgery in Europe. Obes Surg 2015;25:1408-16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.